Extract
Donald Kennedy Joins Board At CytoTherapeutics; Former FDA Commissioner and President Emeritus of Stanford University.
LINCOLN, R.I.--(BUSINESS WIRE)--July 23, 1999--
CytoTherapeutics, Inc. (Nasdaq:CTII) today announced the election of Donald Kennedy, Ph.D., to its Board of Directors. Since 1960...See the full content of this document
Sponsored links
